Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$285.92 - $355.13 $571 - $710
-2 Reduced 0.04%
5,400 $1.72 Million
Q2 2020

Aug 07, 2020

SELL
$141.4 - $257.09 $42,420 - $77,126
-300 Reduced 5.26%
5,402 $1.31 Million
Q3 2019

Nov 13, 2019

BUY
$175.89 - $279.23 $351 - $558
2 Added 0.04%
5,702 $1.01 Million
Q2 2019

Aug 12, 2019

SELL
$250.96 - $284.94 $32.5 Million - $36.9 Million
-129,500 Reduced 95.78%
5,700 $1.49 Million
Q4 2017

Jan 24, 2018

SELL
$168.78 - $199.74 $33,756 - $39,948
-200 Reduced 0.15%
135,200 $25.3 Million
Q3 2017

Oct 24, 2017

BUY
$145.39 - $168.6 $19.7 Million - $22.8 Million
135,400
135,400 $22.8 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Rathbones Group PLC Portfolio

Follow Rathbones Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Rathbones Group PLC with notifications on news.